Jadwal Sholat

Memuat jadwal sholat…

Computer Science editorial

Open AccessOA2026

AOP-Wiki EMOD 3.0: Data Model Expansions and Content Evaluation Framework for Using Agentic AI to Improve Integration between AOPs and New Approach Methodologies (NAMs)

A prototype evidence model demonstrating data model expansions and a vision for transforming the AOP-Wiki to serve regulatory science, computational AOPs, and next-generation risk assessment
Virginia K. Hench; J. Harry Caufield; Sierra A. T. Moxon; Jason M. O'Brien; Stephen W. Edwards· 2026· DOI 10.48550/arXiv.2605.21645

The core problem

Adverse Outcome Pathways (AOPs) are logic models that causally link measurable biological mechanisms to adverse outcomes relevant to chemical regulatory endpoints. They contextualize New Approach Methodologies (NAMs)—in vitro and in silico methods used as alternatives to animal testing—and the sequential events in an AOP serve as multi-scale models spanning biological scales. The AOP-Wiki is the global repository for AOPs and has played a central role in AOP expansion over the past decade. However, constraints within the current data model and application infrastructure limit the AOP-Wiki from supporting continued AOP growth and evolution. The transformative power of agentic AI has re-invigorated AOP-Wiki data modernization efforts at a time when core AOP principles can be harnessed to inform the use of AI for aggregating and structuring AOP-relevant information. Seizing upon this momentum, the authors present AOP-Wiki EMOD 3.0, the third in a series of evidence model prototypes, which concretely demonstrates data model expansions and a vision for how the AOP-Wiki might be transformed to better serve regulatory science and emergent use of AOPs in biomedical and One Health contexts.

Innovation

The primary result is the AOP-Wiki EMOD 3.0 prototype itself, which demonstrates feasible data model expansions and a vision for a transformed AOP-Wiki. The authors report that the prototype concretely shows how the data model can be extended to better support regulatory science and emergent AOP use cases. Key outcomes include: (1) a data model that addresses current constraints, enabling continued AOP growth and evolution; (2) a content evaluation framework that leverages agentic AI for AOP-Wiki internal quality improvement and evidence structuring; and (3) enhanced integration between AOPs and NAMs, facilitating next-generation risk assessment. The prototype lays a foundation for computationally-generated AOPs and qAOPs by providing structured, FAIR, and AI-ready data representations. While specific quantitative metrics (e.g., number of new entities, performance benchmarks) are not provided in the abstract, the work represents a significant step toward modernizing the AOP-Wiki infrastructure. The authors emphasize that the prototype is the third in a series of evidence model prototypes, indicating iterative development and refinement. The results highlight the potential of agenti
Adverse Outcome Pathways (AOPs) are logic models that causally link measurable biological mechanisms to adverse outcomes relevant to chemical regulatory endpoints. They contextualize New Approach Methodologies (NAMs)—in vitro and in silico methods used as alternatives to animal testing—and the sequential events in an AOP serve as multi-scale models spanning biological scales. The AOP-Wiki is the global repository for AOPs and has played a central role in AOP expansion over the past decade. However, constraints within the current data model and application infrastructure limit the AOP-Wiki from supporting continued AOP growth and evolution. The transformative power of agentic AI has re-invigorated AOP-Wiki data modernization efforts at a time when core AOP principles can be harnessed to inform the use of AI for aggregating and structuring AOP-relevant information. Seizing upon this momentum, the authors present AOP-Wiki EMOD 3.0, the third in a series of evidence model prototypes, which concretely demonstrates data model expansions and a vision for how the AOP-Wiki might be transformed to better serve regulatory science and emergent use of AOPs in biomedical and One Health contexts. The work aims to lay a foundation to support computationally-generated AOPs and quantitative AOPs (qAOPs) by focusing on solutions for AOP-Wiki internal quality improvement, evidence structuring to enhance AOP FAIRness and AI-readiness, and improved integration between the AOP framework and NAMs to better serve next-generation risk assessment.
The authors developed AOP-Wiki EMOD 3.0 as a prototype evidence model that extends the existing AOP-Wiki data model. The methodology centers on three interconnected pillars: (1) internal quality improvement of the AOP-Wiki, (2) evidence structuring to enhance FAIRness (Findable, Accessible, Interoperable, Reusable) and AI-readiness, and (3) improved integration between AOPs and NAMs. The prototype concretely demonstrates data model expansions, likely including new entity types, relationships, and metadata fields to capture evidence provenance, quantitative relationships, and links to NAM data. The authors also propose a content evaluation framework for using agentic AI to aggregate and structure AOP-relevant information. While the abstract does not detail specific algorithms, the approach leverages agentic AI—autonomous AI agents capable of complex reasoning and task execution—to assist in populating, curating, and evaluating AOP content. The framework is designed to support computationally-generated AOPs and quantitative AOPs (qAOPs), which require structured, machine-readable data. The methodology emphasizes alignment with core AOP principles to guide AI use, ensuring that AI-generated content adheres to the causal logic and evidence standards of the AOP framework. The prototype serves as a proof-of-concept for transforming the AOP-Wiki into a more scalable, AI-ready platform.

Why it matters

The authors discuss the transformative potential of AOP-Wiki EMOD 3.0 in the context of regulatory science and One Health. They argue that the current AOP-Wiki data model and infrastructure constraints hinder the repository's ability to support the growing demand for AOPs and their integration with NAMs. By expanding the data model and incorporating agentic AI, the prototype addresses these limitations and opens new possibilities for computationally-generated AOPs and qAOPs. The discussion highlights the synergy between AOP principles and AI: core AOP principles (e.g., causal linkage, evidence assessment) can inform the design of AI systems for aggregating and structuring AOP-relevant information, while AI can, in turn, accelerate AOP development and quality assurance. The authors envision a future where the AOP-Wiki serves as a dynamic, AI-augmented knowledge base that supports next-generation risk assessment, reduces animal testing, and advances biomedical and One Health research. They also acknowledge challenges, such as ensuring data quality, maintaining FAIRness, and integrating diverse NAM data types. The work is positioned as a foundation for future research and development, inviting collaboration to realize the full potential of an AI-enhanced AOP-Wiki. The authors conclude that seizing the momentum of agentic AI is crucial for modernizing the AOP-Wiki and maximizing its impact on regulatory science.

Who should read this

CS practitioners and researchers

Opening member content…